← Open Payments lookup

DANIEL D'ANDREA: Open Payments

NPI 1992763866 · HOLMDEL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,322 in 62 payments from 10 companies in 2025. Trend: 2023 $961 · 2024 $874 · 2025 $1,322

Food & beverage: $1,249Education: $73
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.14$393
Lundbeck LLC14$236
Neurocrine BioSciences, Inc.10$187
Otsuka America Pharmaceutical, Inc.3$165
Takeda Pharmaceuticals U.S.A., Inc.7$107
Bausch Health US, LLC6$98
Axsome Therapeutics, Inc.3$58
ABBVIE INC.3$48
Eisai Inc.1$15
E.R. Squibb & Sons, L.L.C.1$14

Products named: REXULTI, AUSTEDO XR, INGREZZA, TRINTELLIX, WELLBUTRIN, Auvelity, VRAYLAR, APLENZIN.

Industry payments across NJ — which companies pay providers there.